Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline

L Ling, W Chik, P Averbuj, PK Pati… - Therapeutic drug …, 2011 - journals.lww.com
Materials and Methods: Two hundred patients at steady-state on long-term perhexiline were
identified retrospectively. The ratio of maintenance dose to steady-state plasma …

Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline

L Ling, W Chik, P Averbuj, P Pati, A Sverdlov, D Ngo… - 2011 - digital.library.adelaide.edu.au
Materials and Methods: Two hundred patients at steady-state on long-term perhexiline were
identified retrospectively. The ratio of maintenance dose to steady-state plasma …

Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline

LH Ling, W Chik, P Averbuj, PK Pati… - Therapeutic drug …, 2011 - pubmed.ncbi.nlm.nih.gov
Materials and methods Two hundred patients at steady-state on long-term perhexiline were
identified retrospectively. The ratio of maintenance dose to steady-state plasma …

[引用][C] Effects of Aging, Renal Dysfunction, Left Ventricular Systolic Impairment, and Weight on Steady State Pharmacokinetics of Perhexiline

LH LING, W CHIK, P AVERBUJ… - Therapeutic drug …, 2011 - pascal-francis.inist.fr
Effects of Aging, Renal Dysfunction, Left Ventricular Systolic Impairment, and Weight on
Steady State Pharmacokinetics of Perhexiline CNRS Inist Pascal-Francis CNRS Pascal and …

Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexiline.

LH Ling, W Chik, P Averbuj, PK Pati… - Therapeutic Drug …, 2011 - europepmc.org
Materials and methods Two hundred patients at steady-state on long-term perhexiline were
identified retrospectively. The ratio of maintenance dose to steady-state plasma …